Neoadjuvant apatinib combined with oxaliplatin and capecitabine in patients with locally advanced adenocarcinoma of stomach or gastroesophageal junction: a single-arm, open-label, phase 2 trial

Table 4 Surgical complications (surgery set, n = 32)

Complications	Any grade	Grade I	Grade II	Grade III
Intra-abdominal abscess, n (%)	4 (12.5%)	0	3 (9.4%)	1 (3.1%)
Wound infection (seroma), n (%)	1 (3.1%)	1 (3.1%)	0	0
Acute cholecystitis, n (%)	1 (3.1%)	0	1 (3.1%)	0
Chylous ascites, n (%)	1 (3.1%)	0	1 (3.1%)	0

ISSN: 1741-7015